[Antiphospholipid antibodies in digestive diseases]

Area of Science:

• Immunology
• Gastroenterology
• Hematology

Background:

• Antiphospholipids are diverse auto-antibodies, including anticardiolipin and lupus anticoagulants.
• These antibodies are found in various conditions and are often associated with thrombotic events.
• Their diagnostic and prognostic significance in digestive tract diseases requires further analysis.

Purpose of the Study:

• To analyze the diagnostic and prognostic value of antiphospholipid antibodies in digestive tract diseases.
• To discuss the implications of these antibodies in various gastrointestinal and hepatic conditions.
• To explore optimal therapeutic and monitoring strategies for patients with antiphospholipid antibodies.

Main Methods:

• Review of existing literature on antiphospholipid antibodies and thrombotic manifestations.
• Analysis of diagnostic tests for anticardiolipin and lupus anticoagulants.
• Evaluation of clinical data linking antiphospholipid antibodies to specific digestive diseases.

Main Results:

• High prevalence of antiphospholipid antibodies in inflammatory bowel disease, though their thrombotic role is debated.
• Strong implication of antiphospholipid antibodies in thrombosis associated with alcoholic liver disease, hepatitis C, cirrhosis, and regenerative nodular hyperplasia.
• Antiphospholipid syndrome is a leading cause of non-tumor-related Budd-Chiari syndrome and is implicated in portal/mesenteric vein thrombosis.

Conclusions:

• Antiphospholipid antibodies play a significant role in thrombotic events within the digestive system, particularly in liver diseases.
• The diverse nature of antiphospholipid antibodies suggests varied mechanisms underlying thrombotic manifestations.
• Further research is needed to clarify the precise role and optimal management of antiphospholipid antibodies in digestive diseases.